Literature DB >> 33501953

Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.

Michael P Busch1, Mars Stone1.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; antibodies; blood donors; seroincidence; seroprevalence

Mesh：

Year:  2021        PMID： 33501953      PMCID： PMC7454349          DOI： 10.1093/cid/ciaa1116

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  7 in total

1.  Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

Authors:  Jefferson M Jones; Mars Stone; Hasan Sulaeman; Rebecca V Fink; Honey Dave; Matthew E Levy; Clara Di Germanio; Valerie Green; Edward Notari; Paula Saa; Brad J Biggerstaff; Donna Strauss; Debra Kessler; Ralph Vassallo; Rita Reik; Susan Rossmann; Mark Destree; Kim-Anh Nguyen; Merlyn Sayers; Chris Lough; Daniel W Bougie; Megan Ritter; Gerardo Latoni; Billy Weales; Stacy Sime; Jed Gorlin; Nicole E Brown; Carolyn V Gould; Kevin Berney; Tina J Benoit; Maureen J Miller; Dane Freeman; Deeksha Kartik; Alicia M Fry; Eduardo Azziz-Baumgartner; Aron J Hall; Adam MacNeil; Adi V Gundlapalli; Sridhar V Basavaraju; Susan I Gerber; Monica E Patton; Brian Custer; Phillip Williamson; Graham Simmons; Natalie J Thornburg; Steven Kleinman; Susan L Stramer; Jean Opsomer; Michael P Busch
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

2.  We stand ready … Blood collection organizations and the COVID-19 pandemic.

Authors:  Hany Kamel
Journal:  Transfusion       Date:  2021-05       Impact factor: 3.157

3.  Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.

Authors:  M Carmen Martin; Ana Jimenez; Nuria Ortega; Alba Parrado; Isabel Page; M Isabel Gonzalez; Lydia Blanco-Peris
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

4.  SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.

Authors:  Daniel Gonçalves Chaves; Ricardo Hiroshi Caldeira Takahashi; Felipe Campelo; Maria Clara Fernandes da Silva Malta; Isabelle Rocha de Oliveira; Edel Figueiredo Barbosa-Stancioli; Maísa Aparecida Ribeiro; Marina Lobato Martins
Journal:  Emerg Infect Dis       Date:  2022-02-18       Impact factor: 6.883

5.  Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.

Authors:  Cassandra N Reedman; Steven J Drews; Qi-Long Yi; Chantale Pambrun; Sheila F O'Brien
Journal:  Microbiol Spectr       Date:  2022-04-12

6.  Seroprevalence of SARS-CoV-2 Antibodies among Vaccinated and Non-Vaccinated Adults in the West Bank: Results of a Repeated Cross-Sectional Study.

Authors:  Faisal Awartani; Nouar Mohammad Qutob; Mohammad Rajab Asia
Journal:  Vaccines (Basel)       Date:  2022-08-17

7.  SARS-CoV-2 Seroepidemiological Investigation in Jordan: Seroprevalence, Herd Immunity, and Vaccination Coverage. A Population-Based National Study.

Authors:  Sami Sheikh Ali; Khalid A Kheirallah; Ghazi Sharkas; Mohammed Al-Nusair; Abdel-Hameed Al-Mistarehi; Mahmoud Ghazo; Ali Zeitawi; Saverio Bellizzi; Mohannad Ramadan; Jomana W Alsulaiman; Hamed Alzoubi; Adel Belbesi; Mohammed Z Allouh
Journal:  Int J Gen Med       Date:  2022-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.